The
The Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) is a professionally independent, scientific institute that specializes in the evaluation of medical procedures and pharmaceuticals. It was established in 2004 as part of the GKV Modernization Act to improve the quality and efficiency of patient care in Germany[1][3].
The main mission of the IQWiG is to improve the quality of patient care through evidence-based evaluations. It places great importance on independence and transparency in its scientific work[1][3].
The IQWiG is involved in international projects for the further development of evidence-based medicine, particularly within the framework of EU programs. It supports the European benefit assessment of pharmaceuticals and advocates for maintaining transparency in these processes[5].
Currently, the IQWiG is participating in the introduction of a Europe-wide benefit assessment of new pharmaceuticals. It is also researching current medical topics such as antibiotic therapy and colorectal cancer screening[5].
